ADVANCED HEALTH LIMITED - Reviewed condensed consolidated annual financial statements for the year ended 30 June 2019

Reviewed condensed consolidated annual financial statements for the year ended 30 June 2019

ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced”)
ISIN Code: ZAE000189049        JSE Code: AVL


 REVIEWED CONDENSED CONSOLIDATED ANNUAL FINANCIAL STATEMENTS FOR THE YEAR ENDED
 30 JUNE 2019


- Revenue increased by 18% to R481.7 million (2018: R406.6 million).
- EBITDA improved by greater than 100% to R17.6 million (2018: Negative EBITDA R0.1 million).
- Headline loss per share from both continuing and discontinued operations improved by 23% to 10.84 cents (2018:
  14.12 cents).
- Loss for the year increased by 5% to R37.9 million (2018: R36.2 million).
- Loss attributable to disposal of Coffs Harbour Day Hospital amounts to R13.5 million (2018: R5.6 million).
- Cash generated from operations increased by greater than 100% to R15.6 million (2018: R5.8 million).
 No dividends declared.

Short-form announcement
The contents of the short-form announcement are the responsibility of the Board of Directors of Advanced Health
Limited. The information in the short-form announcement is a summary of the full announcement and accordingly
does not contain full or complete details. The full announcement is available for inspection at no charge, Monday to
Friday, during office hours at the company’s registered office, the office of the Designated Advisor and on the
Company’s website on http://www.advancedhealth.co.za/ from 29 August 2019. The full announcement is available
on SENS on 29 August 2019 at https://senspdf.jse.co.za/documents/2019/jse/isse/AVL/YE2019AVL.pdf.
The information in this announcement has been extracted from the reviewed condensed consolidated financial
results, but the short-form announcement itself has not been reviewed by the Company’s auditors. Any investment
decisions by shareholders/investors should be based on the full announcement released to the JSE and published on
the Company’s website.

CORPORATE INFORMATION
Advanced Health Limited                                          Registered Address:
(Incorporated in the Republic of South Africa)                   Building 2, Walker Creek Office Park
Registration number: 2013/059246/06                              90 Florence Ribeiro Avenue
ISIN: ZAE000189049 JSE Code: AVL                                 Muckleneuk
                                                                 0002
                                                                 Postnet Suite 668, Private Bag X1
                                                                 The Willows, 0041
 As at 29 August 2019 – the directors of Advanced are as listed below:
 Executive directors                                             Non-Executive Directors
 GJ van Emmenis (Chief Executive Officer)                        FA van Hoogstraten (Lead Independent)
 CP Snyman (Chief Financial Officer)                             CA Grillenberger (Chairman)
 MC Resnik# (Chief Operational Officer Australia)                PJ Jaffe#
 D Goss-Ross (Alternate)                                         CJPG van Zyl
                                                                 Dr WT Mthembu
                                                                 Dr J Oelofse
                                                                 YJ Visser (Alternate)
# Australian

Company Secretary:      M Janse van Rensburg
Auditors:               Mazars
Transfer Secretaries:   Link Market Services Proprietary Limited

Date of announcement: 29 August 2019
Designated Advisor
Grindrod Bank Limited

Date: 29/08/2019 07:05:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.